What we do

At the heart of Therapixel is technology, especially applied mathematics and computer vision. Using various forms of Artificial Intelligence, we develop pertinent products to help healthcare professionals access images more easily and use them in a meaningful way in their specific context.

We aim to facilitate access to the right images and
supplement them with pertinent information


MammoScreen™ is a software that helps in reading digital mammograms to detect and qualify suspicious tissue whether they are likely to be cancerous. Using Deep Learning technologies, the algorithm was trained to recognise cancer lesions on hundreds of thousands of cases that were previously annotated by breast radiologist experts and confirmed when needed by a biopsy.

We bring relevant information to medical professionals at the time they use medical images


Therapixel complies with the ISO 13485 standard.
MammoScreen™ is FDA-cleared and CE-marked. MammoScreen is a medical device CE 0297 class IIa.
The information essential for correct use is described in the user manual to be read carefully.